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The NMDA receptor family of glutamate receptor ion
channels is formed by obligate heteromeric assem-
blies of GluN1, GluN2, and GluN3 subunits. GluN1
and GluN3 bind glycine, whereas GluN2 binds gluta-
mate. Crystal structures of the GluN1 and GluN3A
ligand-binding domains (LBDs) in their apo states
unexpectedly reveal open- and closed-cleft confor-
mations, respectively, with water molecules filling
the binding pockets. Computed conformational free
energy landscapes for GluN1, GluN2A, and GluN3A
LBDs reveal that the apo-state LBDs sample
closed-cleft conformations, suggesting that their
agonists bind via a conformational selection mech-
anism. By contrast, free energy landscapes for
the AMPA receptor GluA2 LBD suggest binding of
glutamate via an induced-fit mechanism. Principal
component analysis reveals a rich spectrum of hinge
bending, rocking, twisting, and sweeping motions
that are different for the GluN1, GluN2A, GluN3A,
and GluA2 LBDs. This variation highlights the struc-
tural complexity of signaling by glutamate receptor
ion channels.
INTRODUCTION
At most excitatory synapses in the brain, the neurotransmitter
glutamate activates a family of ligand-gated ion channels with a
unique tetrameric multidomain architecture, different from other
receptors and ion channels (Mayer, 2011). Due to their central
role in brain function, combined with increasing evidence for
dysfunction in neurological and psychiatric diseases, gluta-
mate receptor ion channels (iGluRs) are important eukaryotic
membrane protein structural targets. Individual iGluR subunits
assemble into three major families: the a-amino-3-hydroxy-
5-methyl-4-isoxazole propionic acid (AMPA), kainate, and
N-methyl-D-aspartic acid (NMDA) receptors, named for their1788 Structure 21, 1788–1799, October 8, 2013 ª2013 Elsevier Ltd Asensitivity to subtype-selective ligands (Watkins and Evans,
1981). Glutamate, or glycine in the case of NMDA receptor
GluN1 and GluN3 subunits, is believed to trigger ion-channel
activation by producing a large conformational change in the
bilobed ligand-binding domain (LBD) of iGluRs.
In canonical models of glutamate receptor ion-channel activa-
tion, in which the four LBDs assemble as a dimer of dimers
(Sobolevsky et al., 2009), binding of neurotransmitters results in
separation of the lower lobes of LBD dimer assemblies, pulling
the ion channel open (Armstrong and Gouaux, 2000). This Venus
flytrap or clamshell model for LBD activation was developed on
the basis of homologywith bacterial periplasmic binding proteins
(Mano et al., 1996; Mao et al., 1982), for which structures had
been solved for the open-cleft apo- and closed-cleft ligand-
bound states (Quiocho and Ledvina, 1996). Subsequent crys-
tallographic studies, on AMPA receptor GluA2 ligand-binding
domains expressed as soluble proteins, revealed a20 difference
in LBD cleft closure for the apo- and glutamate-bound states
(Armstrong and Gouaux, 2000), smaller than the 50 closure
typical for periplasmic proteins but sufficient to produce a 20 A˚
separation of the linkers connecting the LBD to the ion-channel
a-helical transmembrane segments in theGluA2 tetramer (Sobo-
levsky et al., 2009). Although more than 200 agonist-, partial
agonist-, and antagonist-bound crystal structures have since
been solved for iGluR LBDs from the AMPA, kainate, and
NMDA receptor subunit gene families (Mayer, 2011; Pøhlsgaard
et al., 2011; Stawski et al., 2010), the apo state has only been
crystallized for GluA2 (Armstrong and Gouaux, 2000), and more
recently for the orphan receptor GluD2 (Naur et al., 2007), which
similar to GluA2 reveals a large difference in domain closure for
the apo- and ligand (D-serine)-bound states.
Central to the Venus flytrap model for iGluR activation is the
underlying assumption that the open-cleft apo state is a stable
conformational entity distinct from the closed-cleft agonist-
bound state. Support for this model was obtained from the
calculation of free energy landscapes for the GluA2 LBD,
which revealed well-defined, separated basins for the apo-
and agonist-bound states, the conformations of which agreed
well with that for GluA2 LBD crystal structures (Lau and
Roux, 2007). The free energy landscapes were also consistent
with conformational dynamics observed in single-moleculell rights reserved
Table 1. Crystallographic Data Collection and Refinement
Statistics
GluN1 Apo GluN3A Apo
Data Collection
Space group C2 P212121
Unit cell dimensions
a, b, c (A˚) 87.3, 66.4, 63.5 75.0, 83.9, 99.1
a, b, g () 90, 105.2, 90 90, 90, 90
Mol per asymmetric unit 1 2
Wavelength (A˚) 1.0000 0.9999
Resolution (A˚)a 40–1.90 (1.93) 30–1.68 (1.74)
Unique observations 27,791 72,079
Mean redundancyb 3.9 (3.8) 7.1 (7.1)
Completeness (%)b 98.7 (98.0) 98.9 (97.9)
Rmerge
b,c 0.054 (0.59) 0.059 (0.34)
Average I/s(I)b 25.3 (2.5) 27.9 (6.9)
Refinement
Resolution (A˚) 36.9–1.89 29.5–1.68
Protein atomsd 2,215 (50) 4,586 (204)
Glycerol/PO4 (mol) 0/1 2/0
Water atoms 223 579
Rwork/Rfree (%)
e 17.2/20.6 15.4/18.4
Rms deviations
Bond lengths (A˚) 0.01 0.01
Bond angles () 1.29 1.31
Mean B values (A˚2)
Protein overall 34.6 19.4
Main chain/side chain 30.3/38.8 16.5/22.2
Glycerol/PO4 (mol) —/70.7 41.7/—
Water 39.9 30.3
Ramachandran (%)f 98.5/100 98.2/100
aValues in parentheses indicate the low-resolution limit for the highest-
resolution shell of data.
bValues in parentheses indicate statistics for the highest-resolution shell
of data.
cRmerge = (SjII  < II >j)/SI jIIj, where < II > is the mean II over symmetry-
equivalent reflections.
dAlternative conformations.
eRwork = (S jjFoj  jFcjj)/S jFoj, where Fo and Fc denote observed and
calculated structure factors, respectively; 5% of the reflections were
set aside for the calculation of the Rfree value.
fPreferred/allowed conformations.
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2011). Although further, indirect support for the flytrap model
was provided by work on kainate and NMDA receptor subtype
LBDs crystallized with competitive antagonists, which revealed
open-cleft conformations thought to resemble the apo state
(Furukawa and Gouaux, 2003; Mayer et al., 2006), experimental
structures for the apo states of these receptor families have not
been determined, and their conformational stability remains
unknown.
We have now crystallized the NMDA receptor GluN1 and
GluN3A LBDs in their apo states. For GluN1 there is a 25 differ-
ence in domain closure compared with the glycine-bound state,Structure 21, 1788–but for GluN3A there is only a modest 8 opening, such that the
entrance to the binding site is sterically occluded. To explore the
mechanism underlying this surprising difference, conformational
free energy landscapeswere calculated for the apo- and glycine-
bound states of both GluN1 and GluN3A, and for the apo- and
glutamate-bound states of GluN2A and GluA2. These land-
scapes reveal that, in contrast to GluA2, the NMDA receptor
LBDs can access fully closed cleft conformations in the absence
of agonist. GluN1 and GluN3A can also access open-cleft con-
formations that are hyperextended compared with GluN1 LBD
crystal structures in complex with the competitive antagonist
5,7-dichlorokynurenic acid (DCKA). Low free energy LBD con-
formers were then studied using principal component analysis
to evaluate the characteristic large-scale dynamics inherent to
the various LBDs.
RESULTS
Crystal Structure of the GluN1 LBD Apo State
TheGluN1 apo-state structure was solved to a resolution of 1.9 A˚
(Table 1) and adopts an open-cleft conformation similar to that
for the GluA2 and GluD2 LBD apo-state crystal structures. To
estimate the difference in domain closure in the GluN1 apo
LBD crystal structure compared with the GluN1-glycine com-
plex, we performed a least-squares superposition using 142
Ca atoms in lobe 1 (root-mean-square deviation [rmsd] 0.38 A˚),
and then calculated the rotation angle required for superposition
of lobe 2 (rmsd 0.50 A˚ for 95 Ca atoms). This analysis reveals that
the apo structure is open by 25 compared with the glycine com-
plex (Figure 1A). Within the binding pocket, the side chain of
Arg523, which interacts with the ligand a-COOH group in the
glycine andDCKA complexes, adopts a similar extended confor-
mation in both the presence and absence of ligand, and in the
apo state is held in place by a hydrogen bond between the
side-chain guanidinium group and the main-chain carbonyl oxy-
gen of Thr518 (Figure 1B), and by a solvent-mediated hydrogen
bond with the Thr518 side-chain hydroxyl group. The side chain
of Asp732, which binds the glycine a-NH2 group, is disordered in
the apo state and is surrounded by a cluster of water molecules
(Figure 1B). Due to the change in orientation of lobe 2 in the apo
state, Ser688 in a helix F, which also interacts with the ligand
a-COOH group in the glycine complex, moves away from lobe
1 by 4 A˚ and is exposed to solvent. Interlobe interactions, which
are extensive in the GluN1-glycine complex, are limited in the
apo state to a cluster of van der Waals contacts mediated by
Ala734 and Phe738 on a helix I in lobe 2, which pack against
a complementary hydrophobic surface in lobe 1 formed by
Pro407, Phe408, and Phe758. This cluster of contacts is pre-
served across the apo, DCKA, and glycine complex crystal
structures and likely serves as a pivot limiting the relative range
of motion of lobes 1 and 2. An analysis of the dynamics of inter-
actions between lobes 1 and 2 as well as between water mole-
cules and the binding pocket has previously been described
(Kaye et al., 2006).
From an analysis of GluN1 LBD structures in complex with the
competitive antagonist DCKA, which are 16–21 more open
than the glycine complex, it was predicted that the GluN1 apo
state would have a conformation that is similar to the DCKA
complexes (Furukawa and Gouaux, 2003). Least-squares1799, October 8, 2013 ª2013 Elsevier Ltd All rights reserved 1789
Figure 1. Crystal Structure of the GluN1 Apo State
(A) Ribbon plot showing a least-squares superposition using lobe 1
coordinates of the GluN1 apo and glycine complex crystal structures, illus-
trating the 25 difference in domain closure.
(B) Electron density maps (2mFo  DFc, 1.2s) for side chains and water
molecules in the GluN1 apo-state ligand-binding cleft.
(C) Ribbon plot showing a least-squares superposition using lobe 1
coordinates of the GluN1 apo and DCKA (chains A and B) complex crystal
structures, illustrating 10 and 4 rotations of lobe 2 in the antagonist
complexes.
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NMDA Receptor LBD Conformational Distributionssuperpositions using the GluN1 apo-state structure, however,
reveal that following a superposition of lobe 1 (resulting in rmsds
of 0.46 A˚ and 0.50 A˚ for molecules A and B of the DCKA complex1790 Structure 21, 1788–1799, October 8, 2013 ª2013 Elsevier Ltd A[Protein Data Bank (PDB) ID code 1PBQ]), rotations of 10 and 4
are required for a superposition of lobe 2 (rmsds of 0.42 A˚ and
0.37 A˚). Inspection of the superimposed structures reveals
that whereas the GluN1 apo-to-glycine conformational transition
appears to result largely from a hinge-bending motion, the apo-
to-DCKA transition is instead due to a combined sweeping and
twisting motion of lobe 2 (see below), the extent of which is 6
greater for molecule A (Figure 1C).
Crystal Structure of the GluN3A LBD Apo State
The GluN3A apo-state structure was solved to a resolution of
1.7 A˚ (Table 1). The asymmetric unit contains two protomers in
similar conformations, arranged as a head-to-tail dimer. Least-
squares superpositions of the two apo-state LBD protomers
on the previously published GluN3A-glycine complex structure
(Yao et al., 2008) gave rmsd values of 0.54 A˚ and 0.50 A˚ for
lobe 1 (171 Ca atoms). Subsequent superposition of lobe 2
(rmsds 0.56 A˚ and 0.66 A˚ for 92 Ca atoms) required rotations
of only 8, indicating that the GluN3A apo state is substantially
more closed than the GluN1 apo state (Figure 2A). Because
the GluN3A apo-state structures have closed-cleft conforma-
tions, numerous interlobe contacts in the glycine complex are
preserved in the apo state, including hydrogen bonds between
Ser633 and Ser801, Asp845 and Tyr873, and Glu522 and
Thr825, and between the main-chain amide of Ala847 and the
side-chain hydroxyl group of Tyr908. These contacts are formed
between lobe 1 residues and a helices H and I in lobe 2, the tips
of which move only 1–2 A˚ after superposition of lobe 1 (Fig-
ure 2A). By contrast, interlobe interactions formed between the
side chains of Thr614 and Glu799, Lys609 and Glu803, Asn635
and Asp804, and Asn635 and Ser801, which link lobe 1 with helix
F in lobe 2, are disrupted in the apo state due to a 3 A˚ movement
of helix F away from lobe 1.
Within the ligand-binding pocket of the GluN3A apo-state
crystal structure, the side chains of both Arg638 and Asp845,
which bind the ligand a-carboxyl and a-amino groups, adopt
similar extended conformations to those in the glycine-bound
state (Figure 2B). The Arg638 guanidinium group forms a
hydrogen bond with the main-chain carbonyl oxygen of
Ser633, helping to maintain the extended conformation. Like-
wise, the extended conformation of Asp845 is stabilized by a
hydrogen bond with the Ser801 side-chain hydroxyl group. In
addition, the side chains of Arg638 and Asp845 are linked by a
network of well-ordered water molecules. Omit maps for these
solvent molecules are unambiguous and exclude the presence
of glycine (Figure 2B). These water molecules lie in a flask-
shaped cavity, the neck of which has an oval opening of dimen-
sions 2.8 A˚ 3 3.6 A˚, too narrow for glycine to enter the ligand
binding site (Figure 2C). The constriction at the entrance to the
binding site is formed by the side chains of Glu522 and Tyr605
in lobe 1 and by Ser800 and Met844 in lobe 2.
Conformational Free Energy Landscapes
It is not possible to determine from the GluN1 and GluN3A LBD
apo-state crystal structures whether the large difference in
conformation reflects distinct free energy minima between these
NMDA receptor subtypes orwhether the crystal structures repre-
sent conformers belonging to overlapping free energy basins.
To address this issue, we calculated free energy landscapes,ll rights reserved
Figure 3. The Order Parameter (x1,x2) Used to Describe Large-Scale
Conformational Transitions in NMDA and AMPA Receptor LBDs
x1 and x2 each represent the distance (dashed lines) between the centers of
mass of the atoms shown as spheres. Disulfide bonds are shown in red. The
models for GluN2A and GluA2 are based on PDB ID codes 2A5S and 1FTO,
respectively.
Figure 2. Crystal Structure of the GluN3A Apo State
(A) Ribbon plot showing a least-squares superposition using lobe 1
coordinates of the GluN3A apo and glycine complex crystal structures, illus-
trating the 8 difference in domain closure.
(B) Electron density omit maps (mFo  DFc, 5s) for side chains and water
molecules in the GluN3a apo-state ligand-binding cleft, with hydrogen bonds
drawn as dashed lines.
(C) Molecular surface of the GluN3A LBD drawn with transparent gray shading
to illustrate the solvent-filled flask-shaped cavity (blue) located between lobes
1 and 2.
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NMDA Receptor LBD Conformational Distributionsor potentials ofmean force (PMFs), for both the apo- and glycine-
bound forms of GluN1 and GluN3A. For comparison with a gluta-
mate-binding NMDA receptor subtype, we also calculated PMFs
for the GluN2A LBD in both apo- and glutamate-bound states.
The PMFswere computed using an umbrella samplingmolecular
dynamics (MD) simulation strategy in which a two-dimensional
(2D) order parameter, (x1,x2), was used to characterize large-
scale conformational transitions in the LBD as previously per-
formed for the AMPA receptor GluA2 LBD (Lau and Roux,
2007, 2011). x1 and x2 are each center of mass (COM) distances
between atom selections in lobe 1 and lobe 2 (Figure 3; Supple-
mental Experimental Procedures available online). A calculation
of the 2D PMF, W(x1, x2), enables one to estimate the fraction
of the conformational ensemble that populates different confor-
mational states—the probability of observing a conformationStructure 21, 1788–(x1,x2) is proportional to exp[W(x1, x2)/kBT], where kB is
Boltzmann’s constant and T is temperature.
The apo LBD PMFs all feature broad free energy basins (Fig-
ures 4 and 5; Figures S1 and S2), indicating conformational flex-
ibility in the absence of ligands. The global free energy minima
are located as follows: (x1,x2) = (8.7, 10.3 A˚) for GluN1, (9.4,
9.9 A˚) for GluN3A, (12.9, 12.5 A˚) for GluN2A, and (12.1, 11.5 A˚)
for GluA2. The populations for W(x1,x2) < 1 or < 2 kcal/mol are
provided in Table S1. These 2D PMFs can be projected onto a
single dimension, W(x12), where x12 = (x1 + x2)/2 (Figures 4
and 5). This projection results in a simplified conformational
PMF that facilitates comparisons among LBD subtypes. The
1D apo PMFs show that GluN1 and GluN3A have double minima
at 9.7 and 14.5 A˚ for GluN1 and 9.5 and 13.1 A˚ for GluN3A, sepa-
rated by an1 kcal/mol barrier (Figure 4), whereas GluN2A has a
single minimum (Figure 5). As previously reported, the 1D PMF
for GluA2 has a broad basin (Lau and Roux, 2007). The popula-
tions forW(x12) < 1 or < 2 kcal/mol are provided in Table S1. The
populations of the GluN1 and GluN3A LBDs in either the closed-
cleft ‘‘left-hand’’ minima or the open-cleft ‘‘right-hand’’ minima
are also provided in Table S1. To investigate how these NMDA
receptor LBD conformational ensembles compare with those
previously computed for the AMPA receptor GluA2 LBD (Lau
andRoux, 2007) (Figure 5B; Figure S2B), we examined the shape
of the free energy basin by performing a least-squares regres-
sion fit to x2 versus x1 for which W(x1,x2) < 1 kcal/mol. For the
apo GluA2 PMF, this slope has a value of 1.0. By contrast, the1799, October 8, 2013 ª2013 Elsevier Ltd All rights reserved 1791
Figure 4. Conformational Free Energy Landscapes for GluN1 and
GluN3A LBDs
(A) Free energy landscapes for the GluN1 apo state (top) and glycine complex
(bottom) plotted as 2D PMFs (left) and 1D PMFs (right). Contour lines for
W(x1,x2) correspond to a difference of 1 kcal mol
1, with darker colors being
lower in free energy. For the 1D PMFs, the red-shaded region indicates the
range of error estimated by a bootstrap calculation; Figure S1 shows error
ranges for the 2DPMFs. The locations of crystal structures of the apo state and
the following ligand complexes are indicated by yellow points: apo state
(GluN1), cycloleucine (PDB ID code 1Y1M), DCKA (PDB ID code 1PBQ),
glycine (PDB ID codes 1PB7 and 2A5T), D-serine (PDB ID code 1PB8), 1-
aminocyclobutane-1-carboxylic acid (PDB ID code 1Y1Z), and 1-amino-
cyclopropane-1-carboxylic acid (ACPC) (PDB ID code 1Y20).
(B) Free energy landscapes for theGluN3A apo state (top) and glycine complex
(bottom) plotted as 2D PMFs (left) and 1D PMFs (right). The following ligand
complexes are indicated: D-serine (PDB ID code 2RC8), glycine (PDB ID code
2RC7), and ACPC (PDB ID code 2RC9).
See also Figure S1 and Table S1.
Figure 5. Conformational Free Energy Landscapes for GluN2A and
GluA2 LBDs
(A) Free energy landscapes for the GluN2A apo state (top) and glutamate
complex (bottom) plotted as 2D PMFs (left) and 1D PMFs (right). Contour lines
forW(x1,x2) correspond to a difference of 1 kcal mol
1, with darker colors being
lower in free energy; the locations of crystal structures are indicated by yellow
points. For the 1D PMFs, the red-shaded region indicates the range of error
estimated by a bootstrap calculation; Figure S2 shows error ranges for the 2D
PMFs. The location of the glutamate complex crystal structure (PDB ID code
2A5S) is indicated by a yellow point.
(B) Free energy landscapes for the GluA2 apo state (top) and glutamate
complex (bottom) plotted as 2D PMFs (left) and 1D PMFs (right) as described
above for GluN2A. The locations of crystal structures of the following ligand
complexes and apo state are indicated by yellow points: ZK200775 (PDB ID
code 3KG2), apo (PDB ID code 1FTO), 6,7-dinitroquinoxaline-2,3-dione (PDB
ID code 1FTL), glutamate (PDB ID code 1FTJ), and AMPA (PDB ID code 1FTM).
See also Figure S2 and Table S1.
Structure
NMDA Receptor LBD Conformational Distributions
1792 Structure 21, 1788–1799, October 8, 2013 ª2013 Elsevier Ltd All rights reserved
Structure
NMDA Receptor LBD Conformational Distributionssame fit to the apo GluN1, GluN3A, and GluN2A PMFs results in
slopes of 0.4, 0.5, and 0.3, respectively. This analysis indicates
that cleft opening is skewed to be greater along x1 than x2 for
the three NMDA receptor LBDs studied here. Cleft opening for
GluA2, on the other hand, is fairly symmetric in the space of
(x1,x2).
The agonist-bound NMDA receptor LBD PMFs feature free
energy basins that aremuchmore narrow than their apo counter-
parts, indicating, as expected, a stabilization of closed confor-
mations when the binding site is occupied by either glycine
(Figure 4) or glutamate (Figure 5). The global free energy minima
are located at the following (x1,x2) values: (9.2, 10.1 A˚) for GluN1,
(9.0, 10.0 A˚) for GluN3A, (10.1, 12.4 A˚) for GluN2A, and (9.4, 8.4 A˚)
for GluA2. For the glycine-binding subunits GluN1 and GluN3A,
these minima are within 0.5 A˚ of the global minima for the apo
LBDs. This behavior contrasts with that for the GluN2A-gluta-
mate complex, where theminimumshifts 2.8 A˚ along x1, whereas
for the GluA2 LBD glutamate complex the global free energy
minimum shifts 2.7 A˚ along x1 and 3.1 A˚ along x2. Thus, glycine
appears to preserve the closed-cleft left-hand minimum in the
1D apo PMFs of GluN1 and GluN3A while destabilizing the
open-cleft right-hand minimum. The result for GluN1 is consis-
tent with previous MD simulations that suggested a stable
closed-cleft conformation for the apo LBD (Kaye et al., 2006).
Although the position of the minimum shifts for GluN2A, the
free energy basin for the apo LBD overlaps with that of the gluta-
mate-bound LBD. For instance, in the 1D PMF, the minimum
of the glutamate-bound LBD is at x12 = 11.3 A˚, which is
0.5 kcal/mol—within 1 kBT—in the PMF of the apo LBD. These
observations suggest that the NMDA receptor LBDs bind their
agonists via a conformational selection mechanism (Freire,
1998; Ma et al., 1999; Monod et al., 1965). The free energy basin
for apo GluA2, however, does not overlap with that of the gluta-
mate-bound LBD. This behavior suggests that GluA2 binds
glutamate via an induced-fit mechanism (Koshland, 1958).
Although we attempt to differentiate the binding mechanisms
of the LBDs studied here, we note that the conformational selec-
tion and induced-fit models are not mutually exclusive, as has
been pointed out previously (Bucher et al., 2011). For the
GluN1, GluN3A, and GluN2A agonist complexes, the open-cleft
minima at x12 = 14.5 A˚, 13.1 A˚, and 12.7 A˚ found in the apo state
are destabilized by 8.2 kcal/mol, 3.8 kcal/mol, and 2.5 kcal/mol,
respectively. For the GluA2-glutamate complex, the apo mini-
mum at x12 = 11.9 A˚ is destabilized by 7.4 kcal/mol. The fraction
of each conformational ensemble estimated to populate different
regions of the PMF is provided in Table S1. For the GluN2A- and
GluA2-glutamate complexes, the glutamate ligand’s c1 and c2
side-chain torsion angles primarily occupy a single rotameric
state in closed LBD conformations. These torsions, however,
explore additional rotamers when the LBD is in conformations
where x12 > 12 A˚. The c3 torsion is more dynamic within a
closed LBD than c1 and c2, but it, too, explores additional con-
figurations when the LBD is open.
Calculating (x1,x2) for crystal structures of the GluN1 and
GluN3A apo states allows us to locate these in the 2D PMFs (Fig-
ure 4). The crystal structure of apo GluN1 falls near the minima at
larger (x1,x2), whereas the crystal structure of apo GluN3A falls
near the minima at smaller (x1,x2). Crystal structures of GluN1
bound to the antagonists cycloleucine (PDB ID code 1Y1M)Structure 21, 1788–and DCKA (PDB ID code 1PBQ) lie near the minima at smaller
(x1, x2) values than observed for apo GluN1. Antagonist-bound
structures for GluN2A have not been reported, but antagonist-
bound structures for GluA2 lie within the wide basin of low
free energy conformations for the apo state (Figure 5). In con-
trast to the conformationally diverse apo- and antagonist-
bound LBD crystal structures, the agonist-bound crystal
structures are all tightly clustered near the global free energy
minimum for either the glycine- or glutamate-bound proteins
(Figures 4 and 5).
Conformational Principal Component Analysis
Hinge-bending motions are the dominant large-scale structural
variations observed in crystallographic analyses of GluR LBDs
when agonist complexes are compared with the apo state or
antagonist complexes (Bjerrum and Biggin, 2008; Mayer, 2011;
Pøhlsgaard et al., 2011; Stawski et al., 2010). These motions
are highly correlated with the order parameter (x1,x2). Additional
modes of interlobe motions orthogonal to (x1,x2), however, may
also contribute to the conformational dynamics of receptor acti-
vation (Birdsey-Benson et al., 2010). Such secondary modes are
difficult to distinguish from hinge bending using only (x1,x2) as an
indicator. In principle, additional order parameters could be used
to differentiate among the various conformational modes, but
incorporating them into an umbrella sampling strategy would
require substantially more computational time because sam-
pling scales exponentially with the number of order parameters.
We thus sought to characterize LBD motions using principal
component analysis (PCA), which can determine the large-scale
characteristic motions of a protein from an ensemble of protein
configurations (Garcı´a, 1992; Grossfield and Zuckerman, 2009;
Levy et al., 1984). A diagonalized fluctuation correlation matrix
constructed from the LBD configurations yields eigenvectors
and eigenvalues. The eigenvectors, or principal components
(PCs), represent the characteristic motions observed in the
ensemble, and each eigenvalue is the mean square fluctuation
associated with the corresponding eigenvector, as described
in Supplemental Experimental Procedures (Grossfield and
Zuckerman, 2009).
We adopted a pseudo-rigid-body approach in constructing
our ensemble of configurations for PCA. In the initial step of
this approach, the configurations from the simulations are super-
imposed onto the lobe 1 Ca atoms of a reference crystal struc-
ture. The lobe 1 Ca atoms of the reference are then joined to
the lobe 2 Ca atoms of each simulated configuration to produce
the ensemble of configurations. This approach, which is similar
to ones used previously (Bjerrum and Biggin, 2008; Wolter
et al., 2013), prevents fluctuations in the large loop regions of
lobe 1 from entering into the PCA and confounding the examina-
tion of interlobe dynamics. The loop regions within lobe 2, on the
other hand, are small and do not require lobe 2 to be treated as a
rigid body. The PCs were separately computed using coordi-
nates from both apo- and glycine- or glutamate-bound LBD
simulations for which W(x1,x2) < 2 kcal/mol.
The dominant three PCs that characterize interlobe conforma-
tional transitions are described for each of the four LBDs (Figures
6 and 7; Tables S2 and S3;Movies S1 and S2). For the apo LBDs,
PC1 corresponds, as expected, to a hinge-bending motion
(Figures 6A, 6C, 7A, and 7C, left panels) and accounts for the1799, October 8, 2013 ª2013 Elsevier Ltd All rights reserved 1793
Figure 6. Axis of Rotation for GluN1 and GluN3A LBD Principal
Components 1–3
(A) Representative GluN1 apo LBD conformers for PC1, PC2, and PC3. Red
arrows indicate the axis of rotation. PC1, PC2, and PC3 are described as hinge
bending, sweeping, and twisting, respectively.
(B) GluN1-glycine-bound LBD conformers. PC1, PC2, and PC3 are described
as hinge bending, rocking, and twisting (tilted relative to the apo LBD).
(C) GluN3A apo LBD conformers. PC1, PC2, and PC3 are described as hinge
bending, sweeping, and twisting.
(D) GluN3A-glycine-bound LBD conformers. PC1, PC2, and PC3 are
described as rocking, hinge bending, and twisting (tilted relative to the
apo LBD).
See also Tables S2 and S3 and Movie S1.
Figure 7. Axis of Rotation for GluN2A and GluA2 LBD Principal Com-
ponents 1–3
(A) Representative GluN2A apo LBD conformers for PC1, PC2, and PC3. Red
arrows indicate the axis of rotation. PC1, PC2, and PC3 are described as hinge
bending, rocking, and twisting, respectively.
(B) GluN2A-glutamate-bound LBD conformers. PC1, PC2, and PC3 are
described as hinge bending, rocking, and twisting.
(C) GluA2 apo LBD conformers. PC1, PC2, and PC3 are described as hinge
bending, sweeping, and twisting.
(D) GluA2-glutamate-bound LBD conformers. PC1, PC2, and PC3 are
described as hinge bending, sweeping, and twisting.
See also Tables S2 and S3 and Movie S2.
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NMDA Receptor LBD Conformational Distributionsmajority of the proportion of variance in large-scale transitions,
with additional eigenvectors accounting for increasingly smaller
contributions (Table S2). PC2 corresponds to a sweepingmotion
for the apo GluN1, GluN3A, and GluA2 LBDs but a rocking
motion for the apo GluN2A LBD (Figures 6A, 6C, 7A, and 7C,
middle panels). PC3 corresponds to a twisting motion for the
apo LBDs (Figures 6A, 6C, 7A, and 7C, right panels). The differ-
ence between the sweeping and twisting motions is that the
sweeping rotational axis falls ‘‘behind’’ lobe 2, whereas the
twisting axis penetrates lobe 2. The first two eigenvectors have1794 Structure 21, 1788–1799, October 8, 2013 ª2013 Elsevier Ltd Apreviously been computed for the apo GluN1 LBD (Kaye et al.,
2006), and they are similar to the PCs described here.
Upon glycine or glutamate binding to the LBD, PC1 retains a
hinge-bending motion for all LBDs except GluN3A, which con-
verts to a rockingmotion (Figures 6B, 6D, 7B, and 7D, left panels;
Movie S1). Upon glycine binding, PC2 converts from a sweeping
to a rocking motion for GluN1 and from a sweeping to a hinge-
bending motion for GluN3A (Figures 6B and 6D, middle panels).ll rights reserved
Figure 8. Principal Component Distributions for GluN1 and GluN3A
(A) Two-dimensional projection of apo GluN1 LBD conformers generated from
umbrella sampling simulations onto the PC1-PC2 plane withW(x1,x2) < 1 and <
2 kcal mol1 shown in blue and orange, respectively; 1D projections onto either
PC1 or PC2 are represented by marginal histograms; the 2D projections of
selected crystal structures are shown as yellow points.
(B) Projection of apo GluN3A conformers.
(C) Projection of GluN1-glycine conformers.
(D) Projection of GluN3A-glycine conformers.
See also Figure S3.
Figure 9. Principal Component Distributions for GluN2A and GluA2
(A) Two-dimensional projection of apo GluN2A LBD conformers generated
from umbrella sampling simulations onto the PC1-PC2 plane withW(x1,x2) < 1
and < 2 kcal mol1 shown in blue and orange, respectively; 1D projections onto
either PC1 or PC2 are represented by marginal histograms.
(B) Projection of apo GluA2 conformers; the 2D projections of selected crystal
structures are shown as yellow points.
(C) Projection of GluN2A-glutamate conformers.
(D) Projection of GluA2-glutamate conformers.
See also Figure S4.
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NMDA Receptor LBD Conformational DistributionsBy contrast, upon glutamate binding, PC2 retains rocking and
sweeping motions for GluN2A and GluA2, respectively (Figures
7B and 7D, middle panels). PC3 retains a twisting motion for all
LBDs upon either glycine or glutamate binding (Figures 6B, 6D,
7B, and 7D, right panels; Movie S2), although the axis of rotation
undergoes a tilt for the glycine-binding LBDs. Note that because
the PCs were calculated separately for the apo- and glycine/
glutamate-bound LBDs, the same eigenvalue does not neces-
sarily correspond to the same conformation. The proportion of
variance accounted for by each of the different PCs is provided
in Table S2. In comparing the PC motions with (x1,x2), the hinge-
bending motions generally fall along a positive-slope diagonal in
(x1,x2), whereas the other PCs are described in part by configu-
rations off this diagonal. As noted above, the PMFs indicate
that cleft opening appears to be skewed to be greater along x1
than x2 for the three NMDA receptor LBDs compared with
GluA2. This skew is reflected in the tilt of the rotational axes cor-
responding to hinge bending, which is steeper for the glycine-
binding subunits.
PCA has previously been performed for GluA2 using LBD con-
figurations from crystal structures and MD simulations (Bjerrum
and Biggin, 2008; Wolter et al., 2013). The dominant three PCs,
determined using the crystal structures, are hinge-bending (or
clamshell closure), twisting, and rocking motions, listed in order
of decreasing contribution to the proportion of variance. The fact
that the eigenvectors and eigenvalues in these studies are not
identical may be due to the different ensemble of configurationsStructure 21, 1788–used in the PCA (Balsera et al., 1996). Alternatively, the umbrella
sampling approach used here may have introduced some
degree of conformational bias into the ensemble. Umbrella
sampling, however, is not expected to obviate access to low
free energy conformations associated with large-scale motions.
The most energetically relevant conformations are therefore
expected to be included in the structural ensembles used in
the PCA.
Scatter plots of the PCs for NMDA and AMPA receptor LBDs
are shown in Figures 8, 9, S3, and S4. Conformers in either the
apo- or glycine/glutamate-bound state withW(x1,x2) < 1 kcal/mol
and < 2 kcal/mol are plotted separately in order to show how the
distribution of PCs varies with conformational free energy. For
the apo LBDs, the PC1 distributions appear bimodal for GluN1
and GluN3A and unimodal for GluN2A and GluA2 (see the 1D
PC1 projections in Figures 8 and 9). These modalities mirror
the distribution of minima in the apo LBD 1D PMFs. All other
PC distributions, whether for apo- or glycine/glutamate-bound
states, appear unimodal.
The crystal structures that are localized in the 2D PMFs are
also indicated in the PC scatter plots. For GluN1, the apo
structure differs in conformation from the cycloleucine-bound
structures (PDB ID code 1Y1M) primarily in PC1. However,
the differences between the apo structure and the DCKA-
bound structures (PDB ID code 1PBQ) are primarily in PC2
and PC3. For GluN3A, the apo structures (chains A and B) differ
mainly by a small change in PC2. For GluA2, the apo- and1799, October 8, 2013 ª2013 Elsevier Ltd All rights reserved 1795
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NMDA Receptor LBD Conformational Distributionsantagonist-bound structures differ primarily in PC1 with only
small changes in PC2 and PC3.
DISCUSSION
Crystal structures of glutamate receptor ligand-binding
domains provide a detailed but static picture of a highly
dynamic segment of the receptor. The Venus flytrap model
for large-scale rearrangements in response to the binding of
ligands has been extensively studied in other proteins, espe-
cially maltose-binding protein (MBP). On the basis of paramag-
netic relaxation enhancement data, it has been established that
in the apo state, MBP is a rapidly exchanging mixture of a pre-
dominantly (95%) open form, similar to the apo-state crystal
structure, and a minor (5%) partially closed species that dif-
fers from the maltose complex (Tang et al., 2007). In the pre-
sent analysis, we show that the NMDA receptor subunits differ
substantially from GluA2 in two ways. First, the apo state for
GluN1, GluN3A, and GluN2A appears able to adopt the same
fully closed conformation stabilized by agonist, suggesting a
conformational selection mechanism for agonist binding. This
behavior contrasts with that observed for the GluA2 LBD, for
which the agonist complex adopts a more closed conformation
than the apo state can easily access, suggesting an induced-fit
mechanism. Second, the proportion of the LBD population in
the closed-cleft apo state, roughly 11%, 28%, and 15% for
GluN1, GluN3A, and GluN2A, respectively (Table S1), is sub-
stantially greater than the minor closed conformation observed
for MBP.
Our analysis reveals that iGluR apo LBDs can sample a large
region of conformational space. The GluN1 and GluN3A sub-
units exhibit double conformational free energy minima in the
1D PMFs, where the minima are separated by a barrier of
1 kcal/mol, whereas GluN2A and GluA2 are better described
by a single basin. At present, it is unknown whether these
PMFs would change in the context of LBD dimer and tetramer
assemblies and, if so, how. Indeed, PMFs computed using
higher-order LBD assemblies as well as full-length receptor sub-
units, although requiring considerable computational resources,
would provide important insights into the structural thermody-
namics of intact iGluRs.
Comparing crystal structures for iGluR LBD apo states and
antagonist complexes with the free energy landscapes reveals
several features. First, the GluN1 and GluN3A apo-state crystal
structures fall outside both open- and closed-cleft free energy
minima, although they are still in low free energy regions, sug-
gesting modest conformational rearrangement by the crystal lat-
tice. Of note, GluN1 apo-state LBD crystals, which grew in
similar conditions to those reported previously for the GluN1
DCKA antagonist complex (Furukawa and Gouaux, 2003),
crystallized in the same C2 space group, but with a shortening
by one-half of the c axis length. Second, although there is a large
region of conformational space available for the binding of
antagonists, the crystal structures solved to date exploit only a
small region, suggesting that antagonists with different struc-
tures could be designed to trap more open cleft conformations.
The dominant three principal components for all four LBDs
may be classified as hinge-bending, sweeping, rocking, or
twisting motions. PC analysis reveals that the apo-state and1796 Structure 21, 1788–1799, October 8, 2013 ª2013 Elsevier Ltd ADCKA crystal structures have similar extents of hinge bending
(PC1) but different conformations that arise from a combination
of sweeping (PC2) and twisting (PC3) transitions. For the apo
LBDs, PC1 corresponds to hinge bending and PC3 corresponds
to twisting. PC2 corresponds to sweeping for all apo LBDs
except GluN2A, which is rocking. The characteristic motion for
PC2 therefore differentiates neither between NMDA and AMPA
receptors nor between glycine- and glutamate-binding LBDs.
Upon glutamate binding to GluN2A and GluA2, the characteristic
motions for PC1–PC3 remain the same. By contrast, many of
these motions change upon glycine binding to GluN1 and
GluN3A: sweeping converts to rocking for GluN1 (PC2), and for
GluN3A, hinge bending goes to rocking (PC1), and sweeping
to hinge bending (PC2). Additionally, the rotational axis for
twisting undergoes a tilt (PC3). The different behaviors for the
glycine- and glutamate-binding LBDs may result from the
different binding-site architectures and mechanics required to
selectively bind glycine versus glutamate.
In summary, the analyses presented here reveal a rich spec-
trum of ligand and subtype conformational dynamics in iGluR
LBDs that is not apparent from analyses of apo-state crystal
structures nor agonist and antagonist complexes. This spec-
trum likely has multiple functional consequences within an
intact receptor related to the following: the action of full and
partial agonists, the requirement in NMDA but not AMPA recep-
tors for activation by different ligands, and the role of structur-
ally distinct proximal and distal iGluR subunits in ion-channel
gating.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The GluN1 and GluN3A LBD S1S2 constructs were expressed as soluble pro-
teins in OrigamiB (DE3) Escherichia coli (Novagen) and purified to homogeneity
using Ni-NTA affinity, size-exclusion, and SP Sepharose ion-exchange chro-
matography as described previously (Yao and Mayer, 2006). The GluN1
construct contains residues M394–K544 and R663–S800 joined by a GT
dipeptide linker; the GluN3A construct contains residues N511–R660 and
E776–K915 joined by a GT dipeptide linker. To prepare apo proteins, the
following changes were made to the published protocol: low-affinity ligands,
30 mM L-serine for GluN1 and 1 mM L-glutamate for GluN3A, were added
to all chromatography buffers to displace endogenous bound glycine, followed
by exhaustive dialysis over 3–4 days against ligand-free buffer, with a total
volume change of 1015 prior to crystallization; for GluN1, an additional size-
exclusion chromatography step in crystallization buffer was performed prior
to setting up drops, as described in detail in Supplemental Experimental
Procedures.
Structure Determination and Refinement
X-ray diffraction data were collected from single crystals at 100 K at beam-
line ID22 at the Advanced Photon Source. Data sets were indexed, scaled,
and merged using DENZO and SCALEPACK from the HKL2000 suite
(Otwinowski and Minor, 1997). None of the data sets showed twinning
as analyzed by PHENIX xtriage (Adams et al., 2010). The GluN1 apo structure
was solved by molecular replacement with Phaser (McCoy et al., 2007)
using the glycine complex (PDB ID code 1PB7) broken down into separate
search probes for lobe 1 (RFZ1 = 21.8, TFZ1 = 21.6) and lobe 2 (RFZ1 =
14.6, TFZ1 = 35.5). The GluN3A apo structure contained two protomers in
the asymmetric unit; using lobes 1 and 2 of the glycine complex (PDB ID
code 2RC7) as search probes for molecular replacement, the following solu-
tion was obtained (RFZD1a = 21.8, TFZD1a = 21.6; RFZD1b = 21.8,
TFZD1b = 21.6; RFZD2a = 21.8, TFZD2a = 21.6; RFZD2b = 21.8, TFZD2b =
21.6). Alternate cycles of crystallographic refinement with PHENIX (Adamsll rights reserved
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NMDA Receptor LBD Conformational Distributionset al., 2010) coupled with rebuilding and real-space refinement with Coot
(Emsley et al., 2010), using TLS groups determined by motion determination
analysis for GluN1 and GluN3A (Painter and Merritt, 2006) and, at the final
stages of refinement, individual anisotropic displacement parameters for
the GluN1-glycine complex, were performed until Rfree converged to a
stable value and mFo  DFc maps had no interpretable features. The
final models (Table 1) were validated with MolProbity (Davis et al., 2004);
clash scores and MolProbity scores, with values in parentheses for the
percentile compared to structures of comparable resolution, with 100
equaling the best, were GluN1 apo 1.36 (100) and 0.87 (100); GluN3A apo
1.55 (99) and 0.90 (100), respectively. Figures were prepared using PyMOL
(Schro¨dinger).
Free Energy Landscapes,W(x1,x2)
The protein conformational free energy landscapes, or potentials of mean
force,were computed using umbrella sampling simulations. A two-dimensional
order parameter (x1,x2) is used to describe large-scale conformational transi-
tions in each LBD. x1 and x2 each indicate the distance between the COM of
an atom selection in lobe 1 and the COM of an atom selection in lobe 2. The
atom selections are detailed in Supplemental Experimental Procedures.
Coordinates for the umbrella sampling windows consist of LBD conforma-
tions positioned in 1 A˚ increments along x1 and x2. These coordinates were
obtained via targeted (biased-potential) MD simulations using CHARMM
(Brooks et al., 2009) initiated from the following crystal structures: PDB ID
codes 2A5T (glycine-bound GluN1 LBD), 4KCC (apo GluN1 LBD), 2RC7
(glycine-bound GluN3A LBD), 4KCD (apo GluN3A LBD), 2A5S (glutamate-
bound GluN2A LBD), 1FTJ (glutamate-bound GluA2 LBD), and 1FTO (apo
GluA2 LBD). Chain A and residue isomer AC1 were used from the entries
where multiple options exist. Missing residues were built using the ModLoop
server (Fiser and Sali, 2003), and missing residue side chains were built using
SCWRL4 (Krivov et al., 2009). During the targeted MD simulations, rmsd
restraints were applied separately to each lobe to minimize intralobe structural
distortions, and the glycine and glutamate ligands were restrained to remain
docked to lobe 1.
Ninety-three umbrella sampling windows were used to compute each of
the GluN1, GluN2A, and GluN3A PMFs. Computation of the GluA2 PMFs
have been described previously (Lau and Roux, 2007). Sampling for the
GluA2-glutamate PMF was extended by 12 ns from the original 200 ns. All
simulations were performed using CHARMM with explicit solvent at 300 K.
The all-atom potential-energy function PARAM27 for proteins (MacKerell
et al., 1998, 2004) and the TIP3P potential-energy function for water (Jorgen-
sen et al., 1983) were used. The total simulation time for each of the GluN
PMFs is 70 ns. A time step of 2 fs was used. The number of atoms in each
simulation system is 47,000 for GluN1, 44,000 for GluN2A, and 35,000
for GluN3A. Crystallographic waters in each ligand-binding cleft were included
in our models. Na+ and Cl– ions were added in the bulk solution to give 150mM
NaCl and an electrically neutral system. Periodic boundary conditions
were used with an orthorhombic cell with approximate dimensions 88 A˚ 3
78 A˚ 3 72 A˚ for GluN1, 94 A˚ 3 72 A˚ 3 68 A˚ for GluN2A, and 88 A˚ 3 64 A˚ 3
64 A˚ for GluN3A. Harmonic biasing potentials with a force constant of
2 kcal mol1 A˚2 centered on (x1,x2) were used. Each PMF, W(x1,x2), was
computed using the weighted histogram analysis method (Kumar et al.,
1992; Souaille and Roux, 2001) to unbias and recombine the sampled distribu-
tion functions in (x1,x2) from all windows. To prevent ligand dissociation in open
LBD conformations, an asymmetric harmonic potential (force constant of
20 kcal mol1 A˚2) was applied to the distance between the a-carboxylate
oxygen atoms of the ligand and the guanidinium nitrogen atoms of the arginine
in lobe 1 to which it docks (Arg485 for GluA2, Arg523 for GluN1, Arg518 for
GluN2A, and Arg638 for GluN3A) for a subset of window trajectories (6% of
sampling for GluA2, 27% for GluN1, 19% for GluN2A, and 4% for GluN3A).
The restraint was active only when this distance exceeded 2.8 A˚. This restraint
is not expected to adversely affect conformational sampling because dissoci-
ation only occurred in open LBD conformations, where interactions between
the ligand and lobe 2 were weak. The majority of simulations did not involve
the restraint; sampling associated with trajectories where the ligand dissoci-
ated from the LBD was discarded.
The range of variation in each PMF was estimated using a bootstrapping
approach (Wehrens et al., 2000). (x1,x2) for each GluN umbrella window wasStructure 21, 1788–resampled using a window of 300 ps. The resampling window was 200 ps
for GluA2. On average, correlated fluctuations in (x1,x2) decay reasonably close
to zero within these windows, as assessed from a calculation of the autocor-
relation function (Box et al., 2008):
rk =
PNk
i =1

xi  x

xi + k  x

PN
i = 1

xi  x
2
;
where N is the total number of time steps, k is the number of time steps corre-
sponding to a given lag time, x is either x1 or x2, and the overbar indicates an
average.
Principal Component Analysis
PCA calculations involve the diagonalization of the covariance matrix Cij of
positional deviations among an ensemble of protein structures (Garcı´a,
1992; Grossfield and Zuckerman, 2009; Levy et al., 1984):
Cij = hxi  xii

xj  xj

;
where xi represents a specific Ca coordinate, and both the overbar and h,i
indicate average values. The ensemble, generated separately for each iGluR
LBD in either the apo- or glycine/glutamate-bound state, consists of protein
conformers from all umbrella sampling windows in which W(x1,x2) <
2 kcal/mol. This subset includes the vast majority of conformations that are
expected to be observed in a Boltzmann-weighted ensemble while excluding
conformations that are energetically difficult to access. PCs were also
computed using cutoffs of 1 and 3 kcal/mol, and the results were similar.
Only Ca coordinates were used in the calculations. All conformers were first
superimposed onto lobe 1 of a reference structure using a selection of Ca
atoms that excludes flexible loops. The references for GluN1, GluN2A,
GluN3A, and GluA2 are PDB ID codes 4KCC (Figure 1), 2A5S, 4KCD(A)
(Figure 2), and 1FTO(A), respectively. The residue selections are detailed in
Supplemental Experimental Procedures. Next, the lobe 1 Ca atoms of the
reference structure were joined to the lobe 2 Ca atoms of each simulated
conformer to construct an ensemble of pseudo-rigid-body structures. Again,
the residue selections are detailed in Supplemental Experimental Procedures.
The ensembles for apo- and glycine-bound GluN1 include 22,262 and 7,007
conformers, respectively. The ensembles for apo- and glutamate-bound
GluN2A include 12,685 and 7,436 conformers. The ensembles for apo- and
glycine-bound GluN3A include 11,917 and 4,709 conformers. The ensembles
for apo- and glutamate-bound GluA2 include 3,869 and 2,970 conformers.
PCA calculations were performed using Bio3D (Grant et al., 2006). The PCs
characterizing the LBDs in which W(x1,x2) < 1 kcal/mol were obtained by pro-
jection onto the PCs calculated for the LBDs in which W(x1,x2) < 2 kcal/mol.
The axes of rotation characterizing PC1–PC3 were calculated using the
DomainSelect method provided by the DynDom server (Hayward and Berend-
sen, 1998). Endpoint coordinates were generated using Bio3D. Lobe 1 is the
‘‘fixed’’ domain, and lobe 2 is the ‘‘moving’’ domain. For GluN1, lobe 1 is
defined as residues 399–534 and 758–786, and lobe 2 is defined as residues
537–754. For GluN2A, lobe 1 is defined as residues 407–529 and 761–789,
and lobe 2 is defined as residues 532–757. For GluN3A, lobe 1 is defined as
residues 515–649 and 873–901, and lobe 2 is defined as residues 652–869.
For GluA2, lobe 1 is defined as residues 395–496 and 732–760, and lobe 2
is defined as residues 499–728.ACCESSION NUMBERS
Protein Data Bank ID codes for atomic coordinates and structure factors are
4KCC and 4KCD for GluN1 and GluN3A, respectively.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, three tables, and two movies and can be found with this article
online at http://dx.doi.org/10.1016/j.str.2013.07.011.1799, October 8, 2013 ª2013 Elsevier Ltd All rights reserved 1797
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